Related Experiment Videos
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Hepatitis viruses (other than hepatitis B and C viruses) as causes of hepatocellular carcinoma: an update.
Journal of viral hepatitis·2013
Nurses at risk for occupationally acquired blood-borne virus infection at a South African academic hospital.
South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2012
Liver resection for non-cirrhotic hepatocellular carcinoma in South African patients.
South African journal of surgery. Suid-Afrikaanse tydskrif vir chirurgie·2011
Altered lipid profile, oxidative status and hepatitis B virus interactions in human hepatocellular carcinoma.
Prostaglandins, leukotrienes, and essential fatty acids·2009
Interaction between hepatitis B and C viruses in hepatocellular carcinogenesis.
Journal of viral hepatitis·2006
Molecular Mechanisms of Progressive Familial Intrahepatic Cholestasis.
Seminars in liver disease·2026
Metabolic Dysfunction-Associated Steatotic Liver Disease Reprograms the Hepatic Metastatic Niche.
Seminars in liver disease·2026
Advances in Extracorporeal Liver Support.
Seminars in liver disease·2026
Toward Precision Medicine in MASLD: Evolution of Disease Subtyping.
Seminars in liver disease·2026
MASH-Associated T Cell Activation and Neuroinflammation: Evidence for a Hepatosystemic Immune Axis.
Seminars in liver disease·2026
Endothelial Cell Therapy for the Acute and Chronic Liver Disease.
Seminars in liver disease·2026
Development of cecal volvulus after redo pancreas transplantation.
Journal of surgical case reports·2026
Primary Diffuse Large B-Cell Lymphoma of the External Auditory Canal with Extensive Local Extension: A Case Report and Literature Review.
Iranian journal of otorhinolaryngology·2026
Comparison of variably specific Bruton tyrosine kinase inhibitors on platelet aggregation mediated by Fcγ receptor (FcγR) IIa, glycoprotein VI, and platelet endothelial aggregation receptor (PEAR) 1: implications for Bruton tyrosine kinase inhibitors as antithrombotic therapy.
Research and practice in thrombosis and haemostasis·2026